Maryland Lawyer Robert K. Jenner Applauds Pradaxa Decision

Share Article

Maryland attorney Robert K. Jenner applauded today’s decision by the Judicial Panel on Multidistrict Litigation (JPML) to transfer and consolidate all pending and future federal lawsuits involving the anti-coagulant drug Pradaxa. The panel consolidated the actions before The Honorable David R. Herndon of the Southern District of Illinois.

Robert K. Jenner

"Judge Herndon is known to both sides – plaintiffs and defendants alike – to be a fair-minded jurist who knows how to move cases."

“We are very pleased with the JPML’s decision to consolidate the cases into Multidistrict Litigation (MDL),” said Jenner, head of the Mass Tort Division at Janet, Jenner & Suggs, LLC. “We are particularly pleased with the panel’s selection of Judge Herndon. Judge Herndon is known to both sides – plaintiffs and defendants alike – to be a fair-minded jurist who knows how to move cases expeditiously. We look forward to being before him in these cases.”

Chief Judge Herndon is an experienced jurist with MDL experience. He currently presides over MDL 2100 – Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation. Judge Herndon was appointed United States District Judge for the Southern District of Illinois November 16, 1998 and designated Chief Judge October 1, 2007. He received a B.A. in 1974 from Southern Illinois University Edwardsville and earned his Juris Doctorate from Southern Illinois University Carbondale in 1977. Judge Herndon was in private practice from 1977 until 1991 when he became an Associate Judge in Madison County, IL. He served as Associate Judge until commissioned as a United States District Judge upon the nomination of President William J. Clinton and confirmation of the United States Senate."

Pradaxa (dabigatran) is an anti-coagulant that the FDA approved in October 2010 for stroke prevention in patients with atrial fibrillation. Since that time, an alarming number of deaths, internal bleeding and strokes have been attributed to the drug, Jenner noted.

In December 2011, the FDA announced it was conducting a safety review of Pradaxa, including evaluating reports of serious and fatal uncontrolled internal bleeding among patients prescribed the drug, Jenner pointed out. Boehringer Ingelheim is the drug’s manufacturer, he said.

“Our law firm will continue to conduct our own review of reports of Pradaxa side effects and complications from across the country,” said Jenner, who recently spoke on Pradaxa litigation at the American Association of Justice annual meeting in Chicago. “We will continue to help victims of Pradaxa and their lawyers as the litigation progresses.”

About Janet, Jenner & Suggs, LLC

The law firm of Janet, Jenner & Suggs, LLC is a nationally recognized law firm dedicated to representing victims of defective products, medical devices, prescription drugs and medical malpractice. Each of the firm’s principals is named in The Best Lawyers in America® and Super Lawyers®. The firm has offices in Baltimore, Maryland (Commerce Centre East, 1777 Reisterstown Road, Suite 165, Baltimore, MD 21208; local phone number (410) 653-3200); Columbia, South Carolina; and Asheville, North Carolina. The firm accepts clients and referrals from clients and attorneys throughout the country. For more information about Pradaxa, contact the firm at (888) 463-3529 or through the firm’s Pradaxa website.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Teresa Kelly
Teresa Kelly Communications
(512) 328-4276
Email >
Visit website